A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma

Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

(2009) S. Jelic et al.   ANNALS OF ONCOLOGY

Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma

(2009) M. Wang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

(2009) Jorge A. Marrero et al.   GASTROENTEROLOGY

Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

(2009) Anna S. Lok et al.   GASTROENTEROLOGY

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas

(2009) Marc-Oliver Riener et al.   HEPATOLOGY

A Strategy for Precise and Large Scale Identification of Core Fucosylated Glycoproteins

(2009) Wei Jia et al.   MOLECULAR & CELLULAR PROTEOMICS

Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases

(2008) Y. Gu et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

(2007) Masatoshi Makuuchi et al.   HEPATOLOGY RESEARCH